Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes.

Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Abstract Text:

Jean L Wright,Peter G Cordeiro,Leah Ben-Porat,Kimberly J Van Zee,Clifford Hudis,Kathryn Beal,Beryl McCormick,Jean L Wright,Peter G Cordeiro,Leah Ben-Porat,Kimberly J Van Zee,Clifford Hudis,Kathryn Beal,Beryl McCormick,Jean L Wright,Peter G Cordeiro,Leah Ben-Porat,Kimberly J Van Zee,Clifford Hudis,Kathryn Beal,Beryl McCormick,

PURPOSE: To determine intervals between surgery and adjuvant chemotherapy and radiation in patients treated with mastectomy with immediate expander-implant reconstruction, and to evaluate locoregional and distant control and overall survival in these patients. METHODS AND MATERIALS: Between May 1996 and March 2004, 104 patients with Stage II-III breast cancer were routinely treated at our institution under the following algorithm: (1) definitive mastectomy with axillary lymph node dissection and immediate tissue expander placement, (2) tissue expansion during chemotherapy, (3) exchange of tissue expander for permanent implant, (4) radiation. Patient, disease, and treatment characteristics and clinical outcomes were retrospectively evaluated. RESULTS: Median age was 45 years. Twenty-six percent of patients were Stage II and 74% Stage III. All received adjuvant chemotherapy. Estrogen receptor staining was positive in 77%, and 78% received hormone therapy. Radiation was delivered to the chest wall with daily 0.5-cm bolus and to the supraclavicular fossa. Median dose was 5040 cGy. Median interval from surgery to chemotherapy was 5 weeks, from completion of chemotherapy to exchange 4 weeks, and from exchange to radiation 4 weeks. Median interval from completion of chemotherapy to start of radiation was 8 weeks. Median follow-up was 64 months from date of mastectomy. The 5-year rate for locoregional disease control was 100%, for distant metastasis-free survival 90%, and for overall survival 96%. CONCLUSIONS: Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation results in a median interval of 8 weeks from completion of chemotherapy to initiation of radiation and seems to be associated with acceptable 5-year locoregional control, distant metastasis-free survival, and overall survival.

Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Publishing Authors By Initials

JL Wright,PG Cordeiro,L Ben-Porat,KJ Van Zee,C Hudis,K Beal,B McCormick,JL Wright,PG Cordeiro,L Ben-Porat,KJ Van Zee,C Hudis,K Beal,B McCormick,JL Wright,PG Cordeiro,L Ben-Porat,KJ Van Zee,C Hudis,K Beal,B McCormick,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of radiation oncology, biolo

VOLUME: 70

Page Numbers: 43-50

Journal Abbreviation: Int. J. Radiat. Oncol. Biol. P

ISSN: 0360-3016

DAY: 12

MONTH: 09

YEAR: 2007

Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7603616

Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes.

AFFILIATION: Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Radiat Oncol Biol Phys

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes Related Publications

• A cumulative risk factor model for early identification of academic difficulties in premature and low birth weight infants.
• A distinct mechanism regulating a pollen-specific guanine nucleotide exchange factor for the small GTPase Rop in Arabidopsis thaliana.
• Acrylonitrile; its physiology and toxicology.
• Activation of p53 by Dishevelled independent of Wnt or planar polarity pathways.
• Allergens retained in clothing.
• Bacterial-induced hepoxilin A3 secretion as a pro-inflammatory mediator.
• Characterization of interactions between ras family GTPases and their effectors.
• Colonic device. No. 2,458,719.
• Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
• Decision-making for postpartum discharge of 4300 mothers and their healthy infants: the Life Around Newborn Discharge study.
• Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
• Efficacy of Experience Sampling and Day Reconstruction Methods as Measures of Physical Activity Intensity: 1330: Board #93 May 30 11:00 AM - 12:30 PM.
• Female and male rats in late adolescence differ from adults in amphetamine-induced locomotor activity, but not in conditioned place preference for amphetamine.
• Fibrous histiocytoma.
• Identification of the Salmonella enterica serotype Typhimurium SipA domain responsible for inducing neutrophil recruitment across the intestinal epithelium.
• Inpatient Hospital Utilization among the Uninsured Near Elderly: Data and Policy Implications for West Virginia.
• Is the Indiana 1935 Sterilization of the Insane Act functioning?
• Ischaemic complications of Glypressin in liver disease: a case series.
• Lessons in applying health impact assessment to regeneration schemes: the Victorian experience.
• Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes.
• Molecular basis of TCR selectivity, cross-reactivity, and allelic discrimination by a bacterial superantigen: integrative functional and energetic mapping of the SpeC-Vbeta2.1 molecular interface.
• Patient bypass behavior and critical access hospitals: implications for patient retention.
• Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage.
• Streptomyces coelicolor genes ftsL and divIC play a role in cell division but are dispensable for colony formation.
• Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.
• Subretinal hemorrhage masquerading as a hemorrhagic choroidal detachment in a case of nonaccidental trauma.
• Temperature as a determinant factor for increased and reproducible in vitro pollen germination in Arabidopsis thaliana.
• The Arf GEF GBF1 is required for GGA recruitment to Golgi membranes.
• Things that go 'bump' in the house.
• Type 2 diabetes and tuberculosis in a dynamic bi-national border population.